What Changes are in Store for the Cancer Drug Fund?

The National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) England have proposed changes to the operation of the Cancer Drugs Funds. Why does the fund need reform and what will that reform look like? See more here. (Source: Pharmafile, 1/14/16)

You might also be interested in:

Report: NHS Failing to Treat Common Causes of Death June 26, 2018
eDossier System to Offer hēRo3 Model Integration November 8, 2018
Are Vertex, NHS Close to CF Drug Pricing Deal? April 24, 2018
U.K. Ruling Could Save NHS ‘Hundreds of Millions’ Annually September 22, 2018
NICE Rejects MS Drug Ocrevus; MS Society Files Petition September 11, 2018
Real World Data Capabilities: Benchmarking Pharma Companies October 30, 2018
Paying for Digital Health: Payer Insights May 31, 2018